Healthcare Perspectives is a podcast by Siemens Healthineers about medical breakthroughs with the power to improve the lives of patients and their families everywhere.
Meet thought leaders from across the globe, as we discuss our shared vision of fighting the world's most threatening diseases through breakthrough medical technology. Hear how technologies like patient twinning, precision therapy and digitization help medical professionals to make the best possible decisions.
6f0570b4ce66aaf30246c7f725e75cf511acc6f2
Hosted on Acast. See acast.com/privacy for more information.
Healthcare Perspectives is a podcast by Siemens Healthineers about medical breakthroughs with the power to improve the lives of patients and their families everywhere.
Meet thought leaders from across the globe, as we discuss our shared vision of fighting the world's most threatening diseases through breakthrough medical technology. Hear how technologies like patient twinning, precision therapy and digitization help medical professionals to make the best possible decisions.
6f0570b4ce66aaf30246c7f725e75cf511acc6f2
Hosted on Acast. See acast.com/privacy for more information.
Access to quality healthcare is still out of reach for millions worldwide — particularly in low- and middle-income countries and underserved rural areas. One of the biggest drivers of this gap is a shortage of trained healthcare workers, a challenge made worse by workforce migration, limited local training opportunities, and uneven distribution of resources.
In this episode of Healthcare Perspectives, host Hagen Weissapfel, Director of Education and Customer Services for Global Access to Care at Siemens Healthineers, is joined by Melissa Culp, Executive Vice President of Member Engagement at the American Society of Radiologic Technologists (ASRT), and Dr. Geoff Ibbotson, surgeon and Executive Director of the Global Surgery Foundation (GSF). Together, they explore how education and training — scaled through digital innovation and local partnerships — can transform access to care for underserved communities.
From stories of practicing in isolation in remote Nepal, to advancing imaging education in Malawi, to building global learning platforms like SURGHub, Melissa and Geoff share how sustainable, in-country solutions can empower healthcare professionals, break down systemic barriers, and save lives.
What you’ll learn in this episode:
Connect with Hagen Weissapfel
Connect with Melissa Culp
Connect with Geoff Ibbotson
Hosted on Acast. See acast.com/privacy for more information.
Is it possible for artificial intelligence to make healthcare more environmentally sustainable?
In the field of radiology, AI may prove to be transformative. It has the potential to streamline processes, cut costs, and increase accuracy in imaging, diagnostics, and prevention.
When we talk about sustainability, we often think of carbon emissions or climate change. But environmental sustainability means something much broader in healthcare: it’s about how we can preserve resources, whether cost, energy, human capital, and reduce waste and pollution, all while improving health outcomes for everyone, everywhere.
Today, host Vibhas Deshpande, Head of Sustainability Innovation and Research, Americas at Siemens Healthineers, welcomes Dr. Kate Hanneman, cardiac radiologist at the University of Toronto; Dr. Charles Goh, Chief Medical Informatics Officer at Singapore General Hospital; and Tobias Heimann, head of the Department of Artificial Intelligence Germany at Siemens Healthineers, to explore how the rise of artificial intelligence is reshaping the conversation around sustainability in healthcare.
Together, they’re helping define what “responsible AI” really means—and what steps healthcare leaders can take now to ensure that AI benefits patients, clinicians and health systems and preserves global resources.
What you’ll learn in this episode:
Connect with Vibhas Deshpande
Connect with Kate Hanneman
Connect with Charles Goh
Connect with Tobias Heimann
Hosted on Acast. See acast.com/privacy for more information.
Metabolic dysfunction-associated steatotic liver disease (MASLD), also known as fatty liver disease, is a chronic liver condition that affects nearly 1 in 3 people worldwide. It is closely linked to obesity, type 2 diabetes, and metabolic syndrome. Unchecked, it can progress to a more severe form of disease called Metabolic Dysfunction-Associated Steatohepatitis (MASH).
Prognosticating the risk of disease progression in MASLD and MASH has traditionally involved liver biopsy, a process that involves removing a tissue sample with a hollow needle and then examining the sample under a microscope to diagnose and stage disease. However, biopsy has many limitations. Additionally, drug development for MASLD and MASH has proceeded slowly in part due to a reliance on liver biopsy to determine drug efficacy.
Recently, increasing evidence is suggesting that non-invasive options, for example, imaging examinations along with blood tests that assess likelihood of disease progression such as the Enhanced Liver Fibrosis (ELF) Test, may effectively reduce the need for the more invasive alternative. Key experts in MASLD and MASH share their perspectives about how clinical evidence supports a shift in the way patients with MASLD and MASH could be evaluated in clinical practice and in research.
Host Matt Gee, Director of Collaborations and External Engagement at Siemens Healthineers, is joined by Prof. William Rosenberg, Deputy Director of the Institute for Liver and Digestive Health at University College London as well as Dr. Veronica Miller, Director of the Forum for Collaborative Research at the University of California, Berkeley School of Public Health; Dr. Arun Sanyal, Professor of Medicine, Physiology, and Molecular Pathology in the Division of Gastroenterology at Virginia Commonwealth University; and Dr. Michelle Long, International Medical Vice President of Metabolic Dysfunction-Associated Steatohepatitis at Novo Nordisk and Associate Professor in the Section of Gastroenterology and Hepatology at Boston University.
What you’ll learn in this episode:
Connect with Matt Gee
Connect with Veronica Miller
Connect with William Rosenberg
Connect with Michelle Long
Connect with Arun Sanyal
Hosted on Acast. See acast.com/privacy for more information.
A reversible liver condition is the fastest growing cause of liver transplantation in Western countries: Metabolic dysfunction-associated steatotic liver disease—or MASLD—affects patients worldwide. It’s characterized by excessive fat accumulation in the liver and can progress into more severe forms of liver disease, potentially resulting in fibrosis, cirrhosis and liver failure.
Risk factors for developing liver disease include obesity, insulin resistance, type 2 diabetes, and metabolic syndrome. Genetics, unhealthy dietary habits, and a sedentary lifestyle can also play significant roles in its development. Diagnosis typically involves imaging examinations along with blood tests that assess liver function and rule out other causes of liver disease.
Disease management focuses on lifestyle modifications such as diet and exercise, though new medications are now being prescribed to slow and potentially reverse this condition. Regular monitoring of disease progression is also crucial for successful treatment.
In this episode, experts in the field of liver disease address the progress happening in the recognition, diagnosis and treatment of the disease.
Host Matt Gee, Director of Collaborations and External Engagement at Siemens Healthineers, is joined by Dr. Michelle Long, International Medical Vice President of Metabolic Dysfunction-Associated Steatohepatitis at Novo Nordisk and Director of Clinical Research for the Section of Gastroenterology and Hepatology at Boston University; Dr. Arun Sanyal, Professor of Medicine, Physiology, and Molecular Pathology in the Division of Gastroenterology at Virginia Commonwealth University; and Michael Betel, President and Founder of the Fatty Liver Alliance.
What you’ll learn in this episode:
Connect with Matt Gee
Connect with Michelle Long
Connect with Arun Sanyal
Connect with Michael Betel
Hosted on Acast. See acast.com/privacy for more information.
Radiotherapy plays a vital role in cancer treatment. In Europe alone, incidents of cancer are projected to rise around 20% by 2040, mainly due to an increasingly aging population. It’s numbers like these that emphasize the importance of pushing boundaries in radiotherapy.
With AI-optimized workflows, it’s possible to speed up treatment planning and ensure highly personalized therapies and technology like auto contouring can protect healthy organs during irradiation by means of AI. This implementation, however, is often met with challenges like staff shortages and inconsistencies with data collection, highlighting the need for more efficient implementation strategies.
In this episode, experts in the fields of radiotherapy and cancer treatment address the amazing headway being made in the world of radiotherapy as well as some of the key roles that current technology can play in the future.
Host Sasa Mutic, President of Radiation Oncology Solutions at the Varian Business Area of Siemens Healthineers, is joined by Valery Lemmens, a member of the Board of Directors at Maastro Radiotherapy Clinic in the Netherlands and creator of the Dutch Cancer Atlas; as well as Joost Verhoeff, radiation oncologist and professor of radiotherapy at Amsterdam University Medical Center; and Indrin Chetty, Vice Chair and Director of the Division of Medical Physics at Cedars-Sinai in Los Angeles.
What you’ll learn in this episode:
Connect with Sasa Mutic
Connect with Valery Lemmens
Connect with Joost Verhoeff
Indrin Chetty
Hosted on Acast. See acast.com/privacy for more information.
With significant disparities in diagnosis, treatment, and funding when compared to men, women’s health has long been underserved. These gaps affect not only individual health outcomes, they also have societal and economic implications which are highlighted by a recent report by the World Economic Forum and The McKinsey Health Institute which addresses a $1 trillion dollar opportunity to improve lives and economies by mitigating these disparities.
Factors like societal perception, clinical practice, and financial investment all play an important part in women’s health. Addressing the gender health gap and overcoming issues like the misdiagnosis of diseases in women, increasing women’s representation in clinical trials, and advocating for greater financial investment in women’s health are all crucial steps in building a more equal healthcare system for all.
Today, we’re joined by board members of the World Economic Forum’s Global Alliance for Women’s Health to discuss how building a more equitable healthcare system can drive meaningful change, improve healthcare for women, and create access to significant economic potential worldwide.
In this episode, host Elisabeth Staudinger, Member of the Managing Board of Siemens Healthineers, is joined by fellow World Economic Forum’s Global Alliance for Women’s Health board members Nadia Fettah, Minister of Economy and Finance for the Government of Morocco and Shyam Bishen, Head of the Centre for Health & Healthcare at the World Economic Forum.
What you’ll learn in this episode:
Connect with Elisabeth Staudinger
Connect with Nadia Fettah
Connect with Shyam Bishen
Hosted on Acast. See acast.com/privacy for more information.
Sepsis, originally known as blood poisoning, is a life-threatening medical emergency. Tune in to learn about the complexities of sepsis diagnosis, the role of lactate and procalcitonin levels, and the global health challenge it poses. Hear from experts and a sepsis survivor about the advancements in identifying and managing this critical condition.
Sepsis is the body’s extreme response to an infection. It occurs when a pre-existing infection triggers a chain reaction throughout a person's body. Sepsis can be difficult to diagnose because patients present different symptoms, and their observation can be subjective. According to the Global Sepsis Alliance, the disease contributes to approximately one in five deaths worldwide and in the United States alone; it stands as the leading cause of death in hospitals, leading to one in three hospital fatalities. Compounding these mortality rates is a rise in antibiotic and antimicrobial resistance due to overuse or misuse.
Today, we’re joined by experts in the field of diagnostics and critical care as well as a sepsis patient and advocate in order to more acutely understand the disease, its diagnosis, and the advancements in the field.
In this episode, host Ranga Sampath, Senior Vice President and Head of the Center for Innovation in Diagnostics at Siemens Healthineers and Member of the Board of the Sepsis Alliance, welcomes:
What you’ll learn in this episode:
Connect with Ranga Sampath
Connect with Heike Spreter-Krick
Connect with Patti DeJuilio
Connect with Mervyn Singer
Hosted on Acast. See acast.com/privacy for more information.
Regular exercise is one of the most effective methods to keep the heart healthy and efficient. In rare cases, however, there are reports of athletes collapsing mid-game due to cardiac arrest. And while exercise is generally also a key part of the rehabilitation process for those who’ve experienced cardiac events, caution should still be taken. This is where physician input is important, and where testing and regular monitoring can be implemented to reduce the risk of further events.
Today, we’re joined by experts in the fields of sports cardiology and exercise physiology, as well as an athlete with firsthand experience in the matter, to draw attention to the topic of cardiac health and how it pertains to sports medicine.
In this episode, host Myra Cocker, Assistant Professor of Cardiology at Houston Methodist Hospital and Global Director of Clinical Science for Cardiovascular Ultrasound at Siemens Healthineers, welcomes Dr. Jonathan Kim, Associate Professor and Founding Director at Emory University Sports Cardiology and Team Cardiologist for Georgia Tech, the Atlanta Falcons, Hawks, and Braves; as well as Dr. Dominique Hansen, Professor of Rehabilitation and Exercise Physiology in Cardiometabolic Diseases at Universiteit Hasselt in Belgium and Secretary of the European Association of Preventive Cardiology; and retired professional soccer player and cardiology patient Daniel Engelbrecht.
What you’ll learn in this episode:
Connect with Myra Cocker
Connect with Jonathan Kim
Connect with Dominique Hansen
Connect with Daniel Engelbrecht
Hosted on Acast. See acast.com/privacy for more information.
Every year, more than 12 million people suffer from strokes. With 6.5 million dead and many left with permanent disability, it is one of the leading causes of death and disability worldwide.
Today, we’ll learn about the stroke pathway and secondary stroke risk as well as the underlying diseases that are connected to stroke and how they can be identified and treated.
In this episode, host Wiebke Plenkers, product line head for ON THE SPOT, Siemens Healthineers global mobile CT solutions, is joined by Mira Katan, MD, head of Stroke Unit and deputy head of Acute Neurology at University Hospital Basel in Switzerland and Carlos Molina, MD, head of Neurology Section and director of Stroke Unit at Barcelona’s Vall d’Hebron Research Institute.
What You’ll Learn in This Episode:
Connect with Wiebke Plenkers
Connect with Mira Katan
Connect with Carlos Molina
Hosted on Acast. See acast.com/privacy for more information.
In medical imaging, there is a constantly growing gap between the need for diagnostic imaging and the availability of specialist staff. At the same time, groundbreaking developments in the field of artificial intelligence continue to transform the face of the imaging field as we know it. In fact, AI is currently being used as an efficient and cost-reducing solution to a variety of industry challenges.
Today, you’ll hear several panel conversations discussing generative AI in radiology, recorded live at the European Congress of Radiology. Held this year in Vienna, the ECR is one of the leading events in radiology as well as one of the world’s largest international meetings of radiology professionals, radiographers, physicists, and industry representatives.
In this episode, host Fabian Schoeck, Head of Global Product Management for Artificial Intelligence Products at Siemens Healthineers, is joined by Dr. Johannes Haubold, Senior Physician for Clinical AI Integration at University Hospital Essen and Isabelle Ayx, a Senior Radiologist at University Medical Center Mannheim, all based in Germany.
What You’ll Learn in This Episode:
Connect with Fabian Schoeck
Connect with Johannes Haubold
Connect with Isabelle Ayx
Hosted on Acast. See acast.com/privacy for more information.
Lung cancer has the highest mortality rate of all cancers. Globally, it is the deadliest cancer among men and women. One of the biggest contributing factors to lung cancer’s devastation is that it often goes undetected in its early stages. Because the lungs don’t have pain receptors and the chest cavity allows a relatively spacious growing environment for tumors, symptoms typically don’t manifest until the disease has progressed significantly. It’s for these reasons that screening higher-risk patients for lung cancer is so important, as early detection provides the best chance of survival from the disease.
In this episode, Dr. Victoria Schneider, clinical oncology consultant at Siemens Healthineers, is joined by Dr. Richard Booton, clinical director for lung cancer and thoracic surgery at Wythenshawe Hospital and professor of respiratory medicine at the University of Manchester in the UK; Rimma Kondrashova, a radiology resident at Hannover Medical School in Germany; and doctors David Yankelevitz and Claudia Henschke, both radiologists and professors of radiology at Mount Sinai’s Icahn School of Medicine in New York City.
You’ll hear from these experts about the importance of early detection, the programs that have been recently rolled out to increase survival rates, and some of the exciting new advancements in the field.
What You’ll Learn in This Episode:
• Early detection is a key factor in the successful treatment of lung cancer
• Government funded screening programs in the US and the UK have made significant headway in early-stage lung cancer diagnoses
• In Germany, the HANSE Study was created to assess what a successful national lung cancer screening program might look like for the country
• Mobile screening clinics have been implemented in order to move lung cancer screenings out of hospitals and into more readily accessible community spaces
Connect with Victoria Schneider
Connect with Richard Booton
Connect with David Yankelevitz
Connect with Claudia Henschke
Hosted on Acast. See acast.com/privacy for more information.
The carbon footprint of healthcare has been estimated to be 4 to 5% of the worldwide total. To put this number into perspective, if “healthcare” was a country, it would be the fifth largest emitter in the world, coming in just behind China, the United States, India, and Russia. Today we face pressing global issues like climate change and an energy crisis, that impact our health and wellbeing. It becomes crucial then, that the healthcare industry not only takes responsibility for health, but also actively works towards reducing the impact of the environment on people’s health – especially by reducing emissions and consumption of resources.
In this episode, Shikha Pillai, Global Head of Sustainability at Siemens Healthineers, is joined by Dr. Elmar Merkle, Head of the Department of Radiology and Chief Physician for Radiology and Nuclear Medicine at the University Hospital Basel in Switzerland; as well as Dr. Christopher Hess, Chair of the Department of Radiology and Biomedical Imaging at the University of California San Francisco; and Dr. Clemens Juettner, Chief Sustainability Officer at Sana Kliniken in Munich. These experts in radiology and sustainability are talking about what the sector is doing to implement consumption-reducing measures that can lead to not only operational efficiency, but also contribute significantly to our sustainable future.
What You’ll Learn in This Episode:
• For hospitals around the globe, the perpetual “idling” state of imagining machines contributes to the huge carbon footprint of radiology departments.
• On a global average, one hospital bed consumes the same amount of energy as four family homes annually.
• Major strides have been made toward more energy efficient imaging machines, but the most pressing issue is encouraging their use by the medical community.
• The production and delivery of imaging equipment can have massive environmental repercussions.
• It’s not just carbon footprint that can be reduced by greener radiology practices: cost is also a crucial factor.
Connect with Shikha Pillai
Connect with Clemens Juettner
Connect with Christopher Hess
Connect with Elmar Merkle
Hosted on Acast. See acast.com/privacy for more information.
Urine is more than a natural waste product—it can provide a wealth of information about an individual’s overall health, and urinalysis is one of the oldest diagnostic tests in existence. Its use has been dated as far back as Mesopotamia and ancient Greek physician Hippocrates wrote extensively about the use of urinalysis in diagnosing disease in the 6th century BCE.
Today, urinalysis can be used to detect a number of diseases and ailments including urinary tract infections, kidney disease, diabetes, and bladder cancer.
In this episode, Will Hutt, Head of Primary Care, Acute Rapid & Decentralized Urinalysis at Siemens Healthineers, is joined by Nancy Brunzel, a medical laboratory scientist and author of the book Fundamentals of Urine and Body Fluid Analysis and Jon Stradinger, director of assay development for point of care at Siemens Healthineers. We’ll also hear from two experts interviewed for Siemens Healthineers’ recent five-part docuseries about the history of urinalysis: Medical Author and Educator Connie Mardis and Kelly St. Vrain, the head of marketing operations for diagnostics at Siemens Healthineers. They’re discussing the current state of urinalysis, where it could go in the future, and what it all means for the overall patient experience.
Watch Siemens Healthineers’ five-part docuseries Urine, A Liquid Lens into Your Health
What You’ll Learn in This Episode:
• Urinalysis is cost-effective and non-invasive—two reasons it is such a popular diagnostic tool.
• Urinalysis can play an integral role in the early detection of serious diseases.
• Advances in urinalysis such as automated test strip readers have brought new innovations in the consistency and quality control of the test.
• There is a lot of potential for the role that artificial intelligence may come to play in interpreting the data of urinalysis results.
• Urinalysis has existed for millennia, but it will remain an invaluable tool in healthcare.
Connect with Will Hutt
Connect with Nancy Brunzel
Connect with Jon Stradinger
Connect with Kelly St. Vrain
Connect with Connie Mardis
Hosted on Acast. See acast.com/privacy for more information.
A vast number of cancer patients will undergo radiotherapy during their treatment process. Because of this, experts are searching for ways to treat patients as effectively as they can through radiotherapy while also reducing the treatment’s side effects as much as possible. One answer to this is adaptive radiotherapy. Recent advancements in AI and imaging technology have refined the process and made new solutions possible.
These advancements have made it easier for healthcare professionals to adapt treatment to real-time images of the patient's anatomy. This helps to preserve the health of organs surrounding the targeted area and treat patients more effectively.
Today, Sasa Mutic, Senior Vice President at Varian Medical Systems, a Siemens Healthineers company, is joined by Dr. Eric Horwitz, Chair of the Department of Radiation Oncology at Temple University and Fox Chase Cancer Center in Philadelphia; Jennifer Pursley, Medical Physicist and assistant professor at Harvard Medical School; and Kirsten Offereins-van Harten, a senior radiotherapeutic technician at Erasmus University Medical Center in Rotterdam, Netherlands. They discuss how advancements in adaptive radiology technology have transformed the patient experience and the field as a whole—and where it may take us in the future.
What You’ll Learn in This Episode:
Connect with Sasa Mutic
Connect with Dr. Eric Horwitz
Connect with Jennifer Pursley, PhD
Connect with Kirsten Offereins-van Harten
Hosted on Acast. See acast.com/privacy for more information.
The World Health Organization states that access to care is a human right. This means all world citizens should have access to quality health care and services, whenever and wherever they need it. To reach this goal, skilled employees are required at all levels of the healthcare system.
For many low- and middle-income countries, this access is extremely difficult and training and development programs for workers within the field of radiology are often unavailable, only perpetuating the staffing shortage issue.
Of particular concern is staff shortages in radiology and radiotherapy. In this episode, you’ll hear about potential solutions to this problem, including collaboration to facilitate, expand, and improve training coupled with innovations in health technologies.
Today, Ven Virah, Global Contingent Staffing Expert, Workforce Solutions at Siemens Healthineers, is joined by Jeannette Parkes, a clinical director at Access to Care Cape Town and Head of the division of Clinical and Radiation Oncology at Groote Schuur Hospital and the University of Cape Town, as well as Barry Asin, President at Staffing Industry Analysts in Mountain View, California, and Dr. Katja Beitat, Head of Health Tech at Cicada Innovations and Director of Technology and Innovation at Radiology Across Borders in Sydney.
What You’ll Learn in This Episode:
Connect with Ven Virah
Connect with Jeanette Parkes
Connect with Barry Asin
Connect with Dr. Katja Beitat
Hosted on Acast. See acast.com/privacy for more information.
By 2030, the World Health Organization predicts a global shortage of 15 million healthcare workers. As the number of individuals requiring medical care increases, staff shortages are becoming more of a problem. In diagnostic areas with complex indications, the lack of trained and knowledgeable staff can lead not only to errors but also to insufficient time for patient care. Radiology technologists must also be able to perform complex cases, and this requires separate training.
To solve the global staffing shortage, there are two crucial keys: staff recruitment and staff retention — both of which medical schools, hospitals, and industry can play an important role in.
Today, Ven Virah, Global Contingent Staffing Expert, Workforce Solutions at Siemens Healthineers, is joined by Dr. Elliot K. Fishman, Director of the Divisions of Diagnostic Imaging at the Johns Hopkins Hospital and Professor of Radiology at Johns Hopkins University in Baltimore, Maryland; Brad Genereaux, Global Lead of Medical Imaging at NVIDIA; and Elio Arruzza, a lecturer and research academic in medical radiation science at the University of South Australia who also works as a radiographer and medical imaging technologist for Jones Radiology in South Australia.
What You’ll Learn in This Episode:
•That today’s medical students demand a more interactive education (00:13)
•How advances in virtual reality and augmented reality are creating better trained, more confident healthcare providers (02:41)
•With a hands-on approach to education, how students can adapt more easily to in-person training at hospitals and clinics (05:19)
•By using AR and VR simulation training, how healthcare professionals working with medical students can free crucial time while their students train (06:44)
•That artificial intelligence has the potential to act as a research partner, a sounding board, and a failsafe for medical professionals (12:24)
Connect with Ven Virah
Connect with Dr. Elliot Fishman
Connect with Elio Arruzza
Connect with Brad Genereaux
Hosted on Acast. See acast.com/privacy for more information.
Top-class, professional soccer demands the highest performance from athletes’ bodies—both in training and in competition. As the years have progressed and skill and competition have augmented, physical demand from athletes has increased exponentially. In addition to an elite running game, professional footballers are also trained to achieve cannon-like kicks of up to 120 kilometers per hour and withstand headers stronger than the punch of a professional boxer.
In this episode, Dr. Yvonne Braun, Director of Global Clinical Marketing Surgery at Siemens Healthineers, is joined by Dr. Jochen Hahne, an orthopedic specialist and team physician, Prof. Dr. Martin Mack, a specialist in diagnostic and interventional radiology and Prof. Dr. Peter Ueblacker, a team physician and specialist in orthopedics and chirotherapy, all of whom work with FC Bayern, the most successful soccer club in German history.
You’ll hear from the doctors who work with FC Bayern about how advances in orthopedics and medical imaging technology allow them to keep players in the game given all of the continuous stresses they’re under.
What You’ll Learn in This Episode:
•How team doctors with FC Bayern manage injured players
•The way the club’s medical team and its team doctors collaborate to keep players healthy
•Why prevention is the most powerful key to a healthy team
•The importance of time and patience in healing sports-related injuries
•How radiology plays such a major role in FC Bayern’s medical protocol
•The problems that can arise when under-trained, under-experienced radiologists are at the helm
Connect with Prof. Dr. Martin Mack:
Connect with Dr. Yvonne Braun:
Connect with Dr. Jochen Hahne & Prof. Dr. Peter Ueblacker:
Hosted on Acast. See acast.com/privacy for more information.
One of the Covid pandemic's impact is an increase in resignations in healthcare. Combined with rising patient needs, hospitals are now understaffed and looking for new solutions. This is where remote technologies may help. In fact, some hospitals are already seeing success in implementing remote technologies to help in treatment and diagnostics without increasing staff in specific locations. Today Ven Virah, Global Contingent Staffing Expert, Workforce Solutions at Siemens Healthineers, is joined by Anton Quinsten, Chief Radiology Technologist, University Hospital Essen, Germany, Melissa Petrasko, Vice President of Imaging Services, Central Florida Division at AdventHealth, and Ben Archibald-Heeren, Medical Physicist at Icon Cancer Centre, Australia.
They discuss how remote scanning impacts imaging in the medical industry. You’ll also learn how telehealth transforms patient care and the medical staff’s morale. Additionally, you’ll hear about AI's role in the medical industry and the impact it's expected to have in the near future.
What You’ll Learn in This Episode:
Connect with Anton Quinsten:
Connect with Melissa Petrasko:
Connect with Ben Archibald-Heeren:
Connect with Ven Virah:
Hosted on Acast. See acast.com/privacy for more information.
The COVID-19 pandemic exposed many weaknesses in the healthcare systems in both developed and developing countries. At the same time, the pandemic led many healthcare leaders to think out of the box and embrace new technologies in diagnostics, treatment, human resources, funding, and general patient care. Beyond the pandemic, we are seeing a greater commitment to create a more sustainable and resilient healthcare system globally.
Today, Tisha Boatman, Head of Global Access to Care at Siemens Healthineers, is joined by Kelly McCain, Head of Health and Healthcare Initiatives at the World Economic Forum in Geneva, Switzerland, and Isabel Mestres, the CEO of City Cancer Challenge Foundation, an organization that supports cities around the world as they work to improve access to equitable cancer care.
Stay tuned to learn more about the challenge of non-communicable diseases like cancer and heart disease in middle-income and developing countries. You’ll hear about the possible impact that AI is expected to have on the healthcare industry, and how City Cancer Challenge Foundation leverages collaboration to push for meaningful change.
What You’ll Learn in This Episode:
● How the burden of non-communicable disease impacts developing countries (02:21)
● The benefits of standardizing care for non-communicable diseases (04:03)
● The possible impact of AI on the healthcare system (12:05)
● How collaboration can help push for meaningful change in the healthcare system (14:17)
● The impact of COVID-19 on the current healthcare model (25:47)
Connect with Isabel Mestres:
● City Cancer Challenge (C/Can)
Connect with Kelly McCain:
Connect with Tisha Boatman:
Hosted on Acast. See acast.com/privacy for more information.
A diagnosis of cancer is one of the most devastating a person can receive—and worldwide, the number of new cancer diagnoses per year is on the rise, putting even more stress on patients, their families, care teams and health systems.
Today, Gabriel Haras, MD, president of Cancer Therapy Imaging at Varian, a Siemens Healthineers company, is exploring whether digital twin technology could help create a world without fear of cancer. He’s joined by Chloé Audigier, senior AI research scientist at Siemens Healthineers, and Christian Weißenberger, MD, head of outpatient care at the Center for Radiotherapy and Radio-oncology in Freiburg in Breisgau, Germany.
Find out how digital twins could transform the entire cancer care path – from early detection to treatment and follow-up care. You’ll also learn how a digital twin of an organ is created. And you’ll hear what digital twin technology could mean for patients, clinicians, and the future of oncology.
What You’ll Learn in This Episode:
Connect with Christian Weißenberger:
Connect with Chloé Audigier:
Hosted on Acast. See acast.com/privacy for more information.